Fierce Healthcare January 10, 2025
While there was less money in early-stage financing and a surge in publicly disclosed down rounds, investment in venture capital-backed healthcare companies ticked up in 2024, according to HSBC Innovation Banking data.
The amount of total venture investment grew by 17% in 2024 to $14.8 billion, up from $12.6 billion in 2023. There were also more deals done in 2024. New deal activity resumed in 2024, but with a clear shift and investor focus. The challenge of securing follow-on financing, particularly series B rounds, dampened early-stage activity, HSBC analysts wrote in a recent 2024 Venture Healthcare Report.
The mixed outcomes of 2024 represent a rebound from the funding surge of 2021-22, as more companies received reality checks on their valuations...
Today's Sponsors
Today's Sponsor